Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic T lymphocyte responses in vitro.
about
Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systemsEnhancing the immunogenicity of exogenous hepatitis B surface antigen-based vaccines for MHC-I-restricted T cells.In vivo induction of a high-avidity, high-frequency cytotoxic T-lymphocyte response is associated with antiviral protective immunitySmall cationic DDA:TDB liposomes as protein vaccine adjuvants obviate the need for TLR agonists in inducing cellular and humoral responsesInfluenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells.Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigensLiposomes as protein carriers in immunology.Antigen presentation in retroviral vector-mediated gene transfer in vivo.Mechanisms of mouse spleen dendritic cell function in the generation of influenza-specific, cytolytic T lymphocytesVaccination of rhesus monkeys with synthetic peptide in a fusogenic proteoliposome elicits simian immunodeficiency virus-specific CD8+ cytotoxic T lymphocytes.Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes.Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo.Immunostimulatory colloidal delivery systems for cancer vaccines.The next wave of recombinant and synthetic anticancer vaccines.Administration route-dependent vaccine efficiency of murine dendritic cells pulsed with antigens.Induction in vitro of primary cytotoxic T-lymphocyte responses with DNA encoding herpes simplex virus proteins.Recognition by and in vitro induction of cytotoxic T lymphocytes against predicted epitopes of the immediate-early protein ICP27 of herpes simplex virus.Induction of primary, antiviral cytotoxic, and proliferative responses with antigens administered via dendritic cellsUse of fixed autologous stimulator cells to correctly present human immunodeficiency virus type 1 viral peptides to nonhuman primate lymphocytes in proliferation and cytotoxic T-lymphocyte assaysApplications of nanomaterials as vaccine adjuvants.Cationic lipids direct a viral glycoprotein into the class I major histocompatibility complex antigen-presentation pathwayalpha(4)beta(7) independent pathway for CD8(+) T cell-mediated intestinal immunity to rotavirusEnhancing the recognition of tumour associated antigens.Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines.pH-sensitive liposomes for drug delivery in cancer treatment.Two human immunodeficiency virus vaccinal lipopeptides follow different cross-presentation pathways in human dendritic cells.Bridging infectious disease vaccines with cancer immunotherapy: a role for targeted RNA based immunotherapeutics.Delivery of protein antigen to the major histocompatibility complex class I-restricted antigen presentation pathway.The immunological adjuvant and vaccine carrier properties of liposomes.A Lipid Based Antigen Delivery System Efficiently Facilitates MHC Class-I Antigen Presentation in Dendritic Cells to Stimulate CD8(+) T CellsAutologous fixed tumor vaccine: a formulation with cytokine-microparticles for protective immunity against recurrence of human hepatocellular carcinoma.Endocytosis of an HIV-derived lipopeptide into human dendritic cells followed by class I-restricted CD8(+) T lymphocyte activation.DEC-205lo Langerinlo neonatal Langerhans' cells preferentially utilize a wortmannin-sensitive, fluid-phase pathway to internalize exogenous antigen.Monocyte-derived dendritic cells from horses differ from dendritic cells of humans and mice.Immunotherapeutic efficacy of liposome-encapsulated refined allergen vaccines against Dermatophagoides pteronyssinus allergy.Novel Adjuvant Based on the Pore-Forming Protein Sticholysin II Encapsulated into Liposomes Effectively Enhances the Antigen-Specific CTL-Mediated Immune Response.Dendritic cell/macrophage precursors capture exogenous antigen for MHC class I presentation by dendritic cells.Competent dendritic cells derived from CD34+ progenitors express CMRF-44 antigen early in the differentiation pathway.Lipid-Based Particles: Versatile Delivery Systems for Mucosal Vaccination against Infection.Dendritic cell-based approaches to cancer immunotherapy
P2860
Q26996159-03BA18D4-D7DF-4903-AE52-8F9637E8F529Q33605386-1FF2156A-7984-47EC-B17F-61D93AD01F31Q33806244-ACDE1736-F072-47AC-84B0-F5372BB9D685Q34217826-EBD5EAB2-A105-4302-8042-633D5EDA3F4FQ34229490-71BFB8C3-4B4C-4F24-ABE7-4B7710AA7715Q35812875-DE2CC26B-9C7D-459E-9ED3-4063C71DF92DQ36022235-CAC23831-5B95-4B2A-AECB-7F58CC9EFA86Q36029106-6797393D-7D17-44E3-9CBF-CA1D13CB02F6Q36231639-A4136F1B-C871-42D2-9564-D4B362B53692Q36232166-3F8E9930-45D5-4A9C-9A66-DEA4070DBE83Q36365159-815107C1-08CB-4A9D-A172-35127A0525F6Q36367135-9696FB6D-075B-47D2-965D-E9EBA1C2FFE6Q36460849-312BE0F6-3864-4E33-8A14-5EE2FDACDF89Q36470749-43462A6D-D926-481F-9B2E-B5C4ABA0BB86Q36622359-870DA470-D92B-4E07-99FF-BFD74C360DD1Q36635021-5F3423B5-BA73-4DA9-90A7-4FF5D630DCC6Q36640468-8CBC4993-79BB-47A2-BEB9-A38BE3F8652EQ36650065-3FBB4F93-3FA7-48A9-97CE-7B20AD43835CQ36928860-02A34A9C-E10E-4F63-9985-0EB43210C32FQ37159697-5E1085CA-F158-4D4F-B089-770AD5BFDEE3Q37170547-A0696212-EBAE-4BA3-B9B1-4E79BDAF2A8CQ37272014-E33E1778-6FC3-4845-B060-13598D0F5259Q37391100-81C05645-28F6-4364-9E9E-812EA19BBD4DQ37424192-7E9963AA-43F5-42FB-8CF6-CE00136CE112Q38136240-8D0D8896-80AE-45FF-A351-A5A385A3C90FQ39699425-13D379BA-2071-4832-9CD0-3429D0C09A38Q39829133-B9E9FD04-67D7-478E-9F01-DABEBF8428FAQ40381395-D1CFB730-E917-4F55-A90F-DE26A808C8FDQ40499082-6E81A4A8-A70B-48C8-B471-F6AF38CBB67AQ40649527-3FC67DF7-AB64-4016-8CA3-780A20F44890Q40734955-F73B5213-BA43-4601-91D7-8BD7EB2D6CC2Q40840314-CB0FD0CE-7031-47F8-B4A5-58266D06D256Q44665299-BB960E27-1A3B-4D72-9926-FD3CCCF8C55AQ45176884-BAF1AAF5-03E7-4DCC-AAF4-DE51B5143719Q47098828-1CF2E1A5-68C3-473B-A73C-3A4CD1696A8BQ47142328-0D1FD73C-829E-477A-88C4-3CFCC25437C1Q47915872-5BD34099-18A9-4659-9E4A-58EB3462DEA3Q51045165-4481B5D9-C4F7-482A-98AE-52A124D5E389Q52725104-44520D76-35AF-4795-B3DA-4520A16DB8C0Q58409737-A8D5B58E-669B-4A19-86BB-1B08754F9EA2
P2860
Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic T lymphocyte responses in vitro.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Soluble proteins delivered to ...... lymphocyte responses in vitro.
@ast
Soluble proteins delivered to ...... lymphocyte responses in vitro.
@en
type
label
Soluble proteins delivered to ...... lymphocyte responses in vitro.
@ast
Soluble proteins delivered to ...... lymphocyte responses in vitro.
@en
prefLabel
Soluble proteins delivered to ...... lymphocyte responses in vitro.
@ast
Soluble proteins delivered to ...... lymphocyte responses in vitro.
@en
P2093
P2860
P356
P1476
Soluble proteins delivered to ...... lymphocyte responses in vitro.
@en
P2093
P2860
P304
P356
10.1084/JEM.175.2.609
P407
P577
1992-02-01T00:00:00Z